Table: Oncolys Biopharma - 9-MTH parent results

Oncolys Biopharma

01/11/2019 06:00

Nov 1 (Reuters)- 
             Oncolys Biopharma Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Sep 30, 2019        Sep 30, 2018     Dec 31, 2019 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            640 mln             118 mln                    
                (+440.5 pct)        (+308.0 pct)                  
  Operating     loss 586 mln        loss 915 mln                  
  Recurring     loss 587 mln        loss 899 mln                  
  Net           loss 590 mln        loss 901 mln                  
  EPS          loss 42.73 yen      loss 79.31 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div            NIL                 NIL                      
  -Q4 div                                NIL              NIL     
  
  NOTE - Oncolys Biopharma Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T